TCT 2025 Late-Breaking Science Collection

  • Published:  21 October 2025
  • Views: 

    Views Icon

    1221

  • Likes: 

    Heart Icon

    0

Up Next

TCT 2025 Late-Breaking Science Collection

  • Published:  21 October 2025
  • Views: 

    Views Icon

    1221

  • Likes: 

    Heart Icon

    0

Average (ratings)
No ratings
Your rating
About the episode

TCT 2025 - Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, SA) reviews the most impactful late-breaking trials in structural cardiology, coronary interventions, and AI from TCT 2025.

Key trials:
0:40 – SUMMIT MAC (Tendyne TMVR in MAC)
2:25 – PARTNER 3 (7-year TAVR outcomes)
4:10 – CONFIRM 2 AI & angiography-derived physiology
6:05 – SHORTCUT (IVL vs cutting balloon)
7:45 – VICTORY (OPN vs IVL)

Editor: Mirjam Boros, Jordan Rance
Videogrphers: Tom Green, Dan Brent

Support: This is an independent interview produced by Radcliffe Cardiology.

Overview

Stay Updated with Our TCT 2025 Video Coverage

We’re bringing you independent, critical insights straight from TCT 2025.

Join Prof Nicolas Van Mieghem in Cardiology Conference Perspectives as he discusses what the late-breaking data could mean for your practice.

Don’t miss our short Expert Interviews with investigators, offering concise analyses and practical take-home messages.

Hear Dr Mirvat Alasnag and Dr Rasha Al-Lamee share their views on the data they believe will have the greatest impact on clinical practice.

Follow the hot topics driving innovation in interventional cardiology, and stay tuned for fresh perspectives, real-world insights and global viewpoints, all coming soon on Transcatheter Academy.

More from this programme

Part 3

NVM Cardiology Conference Perspectives

A focused video series where Prof Nicolas Van Mieghem offers expert reflections on the most impactful late-breaking trials shaping interventional cardiology at TCT 2025.

Faculty Biographies

Mirvat Alasnag

Mirvat Alasnag

Director of Catheterization Laboratory

Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.

 

Academic History

Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.